Multifactorial intervention
Multifactorial intervention has been studied in 20 papers since 2016: 7 trials and 1 observational study in people, 12 reviews; 3 in the past year. The newest paper, Nov 3, 2026: “Complication Prevention Beyond Glycaemic Control in Type 2 Diabetes: Cumulative Metabolic Exposure, Organ Vulnerability and Treatment Durability”.
20 papers study it33 findingsUpdated
1 new paper in 30 daysSee all 20 papers on multifactorial intervention
At a glance
Independent labs found the same change in people. 11 independent labs in 7 countries.
“Short Physical Performance Battery score improved 1.58 and 1.36 points (p < .001), handgrip strength 2.84 and 2.49 kg (p < .001), functional reach 4.3 and 4.52 cm (p < .001)”
None of its findings points the other way.
- 11 independent labs in 7 countries
- Funders: Instituto de Salud Carlos III and others
- 3 of 33 findings with company ties
- Human trial7
- Humans1
Studies in people
See all 7 studies of multifactorial intervention in people7 studies gave multifactorial intervention to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Improves liver Frailty Index down: Decreases C-reactive protein down: Decreases caspase-cleaved keratin 18 | Randomized trial12 months | 37 peoplePatient cohorts | Biomolecules, Nov 6, 2024 |
down: Prevents frailty22.1% vs. 32.8%, p = 0.013 | Randomized trial36 months | 135 peopleBoth≥80 yearsThe oldest old | Gerontology, Feb 4, 2022 |
down: Lowers the risk of long-term care insurance certificationHR 0.51, 95% CI 0.17-1.54; 1.8 vs 3.6 per 1,000 person-years; not statistically significant down: Decreases long-term care costcost ratio 0.36, 95% CI 0.11-1.21, P=0.099; 375,308 vs 1,040,727 JPY cumulative | Trial32 months | 140 peoplecommunity-dwelling older adultsOlder adults | [Nihon koshu eisei zasshi] Japanese journal of public health, Jan 1, 2020 |
no change: Has no effect on total direct medical costs€12,126,900 intensified vs €11,181,700 conventional down: Decreases cost per person-year€8725 intensified vs €10,091 conventional per person-year down: Decreases inpatient admission costs related to cardiovascular disease | Randomized trial21.2 years | 160 peopleIntensified vs conventional treatment | Diabetologia, Oct 6, 2018 |
up: Improves physical function1.58 (p <.001) at 3 months, 1.36 (p <.001) at 18 months up: Improves cognitive function down: Decreases number of prescriptions-9.6% vs +4.5% | Randomized trial12 weeks | 352 people75.3% were femalemean age 77.3 yearsCommunity-dwelling adults aged older than 65 | The journals of gerontology. Series A, Biological sciences and medical sciences, Jan 19, 2018 |
What did studies of multifactorial intervention find?
21Studies of multifactorial intervention measured 21 outcomes, among them falls, frailty and physical function.
Falls
downin humans4RR 0.87
4 studies
Falls
downin humans4RR 0.87
Multifactorial intervention decreases falls in humans (community-dwelling) (IRR 0.84, 95% CI 0.74-0.95).
Reviewcommunity-dwellingn = 27,784
Multifactorial intervention decreases falls in RAC and community settings.
Reviewin RAC and community settings
Multifactorial intervention decreases falls in humans.
Review
Multifactorial intervention decreases falls in humans (community-dwelling) (RR 0.87, 95% CI 0.80-0.95).
Reviewcommunity-dwelling
Frailty
downin humans4
4 studies
Frailty
downin humans4
Multifactorial intervention prevents frailty in humans (22.1% vs. 32.8%, p = 0.013).
Human trial36 monthsn = 135
Multifactorial intervention decreases frailty in humans (23.9% vs. 8.2%).
Human trial6-monthn = 200
Multifactorial intervention decreases frailty in humans (Reduction of 1.0 frailty criterion (95% CI 0.4 to 1.5)).
Human trialFrail community-dwelling people compliant with allocated treatment; complier average causal effect12 months
Multifactorial intervention decreases frailty in humans (multifactorial interventions) (in 75% of studies).
Reviewmultifactorial interventions
Physical function
upin humans2
2 studies
Physical function
upin humans2
Multifactorial intervention improves physical function in humans (1.58 (p <.001) at 3 months, 1.36 (p <.001) at 18 months).
Human trial12 weeksn = 352
Multifactorial intervention improves physical function in humans (prefrail/frail community-living elderly) (SPPB +1.58 and +1.36 points; handgrip +2.84 and +2.49 kg; functional reach +4.3 and +4.52 cm).
Human trialprefrail/frail community-living elderly3 and 18 monthsn = 352
Multifactorial intervention improves physical function in humans (multifactorial interventions) (in 58% of studies).
Reviewmultifactorial interventions
Liver Frailty Index
upin humans2
2 studies
Liver Frailty Index
upin humans2
Multifactorial intervention improves Liver Frailty Index in humans.
Human trial12 monthsn = 10
Multifactorial intervention improves liver Frailty Index in humans (compared with control group).
Human trialcompared with control group12 months
Number of prescriptions
downin humans1
1 study
Number of prescriptions
downin humans1
Multifactorial intervention decreases number of prescriptions in humans (-9.6% vs +4.5%).
Human trial12 weeksn = 352
Multifactorial intervention decreases number of prescriptions in humans (prefrail/frail community-living elderly) (-1.39 and -1.09 prescriptions).
Human trialprefrail/frail community-living elderly3 and 18 monthsn = 352
Isoleucine
upin humans1
1 study
Isoleucine
upin humans1
Multifactorial intervention increases isoleucine in humans (compared with control group).
Human trialcompared with control group12 months
Caspase-cleaved keratin 18
downin humans1
1 study
Caspase-cleaved keratin 18
downin humans1
Multifactorial intervention decreases caspase-cleaved keratin 18 in humans (compared with control group).
Human trialcompared with control group12 months
C-reactive protein
downin humans1
1 study
C-reactive protein
downin humans1
Multifactorial intervention decreases C-reactive protein in humans (compared with control group).
Human trialcompared with control group12 months
Long-term care cost
downin humans1
1 study
Long-term care cost
downin humans1
Multifactorial intervention decreases long-term care cost in humans (compared with propensity-matched non-participants) (cost ratio 0.36, 95% CI 0.11-1.21, P=0.099; 375,308 vs 1,040,727 JPY cumulative).
Human trialcompared with propensity-matched non-participantsresistance exercise, nutritional and psychosocial programs32 monthsn = 140
Inpatient admission costs related to cardiovascular disease
downin humans1
1 study
Inpatient admission costs related to cardiovascular disease
downin humans1
Multifactorial intervention decreases inpatient admission costs related to cardiovascular disease in humans (intensified vs conventional treatment).
Human trialintensified vs conventional treatmentintensified target-driven7.8 years intervention
Cost per person-year
downin humans1
1 study
Cost per person-year
downin humans1
Multifactorial intervention decreases cost per person-year in humans (intensified vs conventional treatment) (€8725 intensified vs €10,091 conventional per person-year).
Human trialintensified vs conventional treatmentintensified target-driven7.8 years intervention
Total direct medical costs
no changein humans1
1 study
Total direct medical costs
no changein humans1
Multifactorial intervention showed no clear effect on total direct medical costs in humans (intensified vs conventional treatment) (€12,126,900 intensified vs €11,181,700 conventional).
Human trialintensified vs conventional treatmentintensified target-driven21.2 years
Cognitive function
upin humans1
1 study
Cognitive function
upin humans1
Multifactorial intervention improves cognitive function in humans.
Human trial12 weeksn = 352
Adherence to Mediterranean diet
upin humans1
1 study
Adherence to Mediterranean diet
upin humans1
Multifactorial intervention increases adherence to Mediterranean diet in humans.
Human trial6-monthn = 200
Functional capacity
upin humans1
1 study
Functional capacity
upin humans1
Multifactorial intervention improves functional capacity in humans.
Human trial6-monthn = 200
All 21Fewer
What is multifactorial intervention linked with?
2Studies link multifactorial intervention with 2 measures: falls and long-term care insurance certification.
Falls
downin humans1
1 study
Falls
downin humans1
Multifactorial intervention lowers the risk of falls in humans (-11%, RR+=0.89).
Review
Long-term care insurance certification
downin humans1HR 0.51
1 study
Long-term care insurance certification
downin humans1HR 0.51
Multifactorial intervention lowers the risk of long-term care insurance certification in humans (compared with propensity-matched non-participants) (HR 0.51, 95% CI 0.17-1.54; 1.8 vs 3.6 per 1,000 person-years; not statistically significant).
Human trialcompared with propensity-matched non-participantsresistance exercise, nutritional and psychosocial programs32 monthsn = 140